Objective: To examine peripheral leukocyte Dectin-1 regulation in clinically relevant models of fungal and polymicrobial sepsis.
T he critically ill patient frequently develops a complex disease spectrum that can include sepsis syndrome and/or septic shock (1) . Critically ill patients can also exhibit profound immunosuppression which leads to increased susceptibil-ity to opportunistic pathogens, such as Candida species (2, 3) . We do not fully understand the cellular mechanisms that predispose the critically ill host to infection; however, recent evidence has provided significant insights into the cellular mechanisms that are involved in pathogen recognition. The innate immune system recognizes pathogens by means of evolutionarily conserved pattern recognition receptors (PRRs) (4) . PRRs recognize and interact with pathogen-associated molecular patterns (PAMPs) (4) . Glucans are fungal PAMPs that are present in the cell wall of fungi, plants, and certain bacteria (5, 6) . Purified glucans are known to stimulate innate immunity and to promote survival in a variety of infection models (7) (8) (9) . Dectin-1 is the primary PRR for glucans (10 -14) . Dectin-1 is expressed at high levels on monocytes, neutrophils, and macrophages and at lower levels on dendritic cells and some T cells (11, 12, 14) . Interaction of glucan with Dectin-1 results in internalization of the complex in vitro (15, 16) and decreases Dectin-1 ex-pression on blood neutrophils and monocytes for 7 days in vivo (17) .
Dectin-1 is thought to be an important sentinel receptor for fungal infections (13) . The fungal cell wall contains large amounts of glucan (5, 6) . Additionally, fungi release glucan into the extracellular milieu (18) . Binding of Candida albicans blastospores to Dectin-1 is glucan dependent and results in internalization of the yeast and production of tumor necrosis factor (TNF)␣ and reactive oxygen species (13, 19) . However, the importance of Dectin-1 in the response to C. albicans infection is controversial. Taylor et al (20) have recently reported that mice which are genetically deficient in Dectin-1 show increased mortality after C. albicans infection. In striking contrast, Saijo et al (21) reported that survival in C. albicans infection is similar in Dectin-1 knock-out and wild-type mice. However, Saijo et al (21) reported that Dectin-1 plays a role in the response to Pneumocystis carinii infection. Thus, both of these studies indicate a role for Dectin-1 in response to fungal infection.
However, these data also indicate that additional studies are required to more precisely determine the role of Dectin-1 in response to fungal infection. These data also suggest that there may be differential responses of Dectin-1 to various infections.
Dectin-1 may also be involved in the response to bacterial and/or polymicrobial infection. Administration of the Dectin-1 ligand glucan phosphate improves survival rates in cecal ligation and puncture (CLP)-induced polymicrobial sepsis (22) . The molecular mechanisms responsible for protection are not fully known, but glucan ligands blunt the early increase in nuclear factor kappa B and nuclear factor interleukin (IL)-6 activation (7) and activate the phosphoinositide-3kinase pathway (22) , thereby limiting the host proinflammatory response to the septic injury. Because Dectin-1 is the primary receptor for glucans and the first step in the response to glucan is binding of the ligand by PRRs, it is currently thought that Dectin-1 is involved in the protective response of glucans in surgical sepsis (13) . How Dectin-1 levels may be affected by ongoing sepsis has not been investigated.
The majority of studies addressing the interaction of microbes and Dectin-1 have been conducted in vitro (10, 13, 19) . We have established that in vivo administration of highly purified glucan decreases leukocyte membrane-associated Dectin-1 (17) , however, the effect of clinically relevant fungal or bacterial infections on in vivo Dectin-1 levels has not been examined. The goal of the present study was to determine the effect of clinically relevant polymicrobial sepsis on in vivo leukocyte Dectin-1 expression and to compare and contrast this effect with that of a clinically relevant fungal infection.
MATERIALS AND METHODS
Mice. Age-and weight-matched adult male outbred mice (ICR/HSD) were obtained from Harlan Sprague-Dawley (Indianapolis, IN). The animals were maintained on standard laboratory chow and water ad libitum with a 12-hour light/dark cycle. Serologic testing confirmed that the mice were virus free. All animal procedures were reviewed and approved by the institutional review board at the James H. Quillen College of Medicine, East Tennessee State University.
Polymicrobial Sepsis. Polymicrobial sepsis was induced by CLP (three animals per time point) as previously described (23, 24) . Survival analysis of this model of sepsis resulted in an onset of mortality at 22 hours and a median survival time of approximately 30 hours with 20% long-term survival (data not shown). Sham surgery (laparotomy alone) and animals that underwent no surgery or anesthesia were used as controls (three animals per group per time point). Mice were euthanized by CO 2 asphyxiation 0, 3, 6, 12, and 24 hours postoperatively, and peritoneal cells, spleens, and blood were harvested and screened for Dectin-1 expression by flow cytometry.
Fungal Infection. Fungal infection was induced (three animals per time point) by intravenous administration of C. albicans (1 ϫ 10 5 colony-forming units). The C. albicans used in this study is a clinical isolate used as a reference control in the Microbiology Clinical Laboratory at the Quillen College of Medicine. Survival analysis of this strain and dose of C. albicans resulted in a median survival time of 13 days and time to 100% mortality of 21 days (data not shown). Mice were euthanized by CO 2 asphyxiation on days 1, 3, 5, 7, and 14, and blood, kidneys, and spleens were harvested from control and infected mice and screened for Dectin-1 expression by flow cytometry (blood and spleens) or immunohistochemistry (kidneys). Control mice (three animals per time point) were administered 5% dextrose in water.
Dectin-1 Expression on Cultured Primary Murine Neutrophils. Peritoneal neutrophils were harvested from ICR/HSD mice 18 hours after intraperitoneal injection of thioglycollate. After removal of adherent cells, the purity of neutrophils was 50% to 70%. The neutrophils were cultured in the presence of 1 g/mL Saccharomyces cerevisiae-derived glucan phosphate (25) , C. albicans blastospore-or hyphal-derived glucan phosphate (26) , mannan (Sigma, St. Louis, MO) or lipopolysaccharide (LPS) (Sigma) alone or in combination for 3 hours. In a separate study, neutrophils were incubated with glucan phosphate (1 g/mL), TNF␣ (0.1, 1, and 10 ng/mL; BD Pharmingen, San Diego, CA), IL-6 (0.1, 1, and 10 ng/mL; BD Pharmingen), IL-17 (0.1, 1, and 10 ng/mL; R and D Systems, Minneapolis, MN), or L cell-conditioned media (30% in RPMI) for 3 hours at 37°C. The cells were stained with anti-Dectin-1 (R and D Systems) and antineutrophil (Serotec, Oxford, UK) antibodies and analyzed by flow cytometry. After gating to the neutrophil population, the percentage of cells positive for Dectin-1 was determined.
Apoptosis of Cultured Primary Murine Neutrophils. Peritoneal neutrophils were harvested and treated as for the Dectin-1 expression study. The cells were washed and pelleted. The pellets were suspended in 70% ice-cold ethanol and stored at Ϫ20°C for at least 24 hours. The cells were washed three times and then incubated with 50 g/mL propidium iodide (Molecular Probes, Eugene, OR) and 10 g/mL RNaseA (Thermo Scientific, Surrey, UK) for 30 minutes at 37°C. Apoptosis was measured by determining the subG0 population by flow cytometry.
Flow Cytometry. Whole blood was collected into EDTA Microtainers (BD Vacutainer Systems, Franklin Lakes, NJ). Splenocytes were isolated by teasing and erythrocytes were lysed with PharmLyse buffer (BD Pharmingen). Resident peritoneal cells were obtained by lavage. Leukocytes and neutrophils were blocked with 5% rabbit serum, 0.5% bovine serum albumin, and 5 mM ethylenediaminetetraacetic acid with anti-murine CD16/32 (BD Pharmingen) before staining. Leukocytes were stained with biotinylated rat anti-Dectin-1 (14) or biotinylated goat anti-Dectin-1 (R and D Systems), antineutrophil (clone 7/4) (Serotec), anti-F4/80 (Caltag, Burlingame, CA), and anti-CD3 (BD Pharmingen) or their isotype control antibodies. Staining was performed according to the protocol described by BD Pharmingen. Biotinylated antibodies were detected by streptavidin-phycoerythrin (BD Pharmingen). Cells were suspended in Pharmingen Stain Buffer and analyzed using a FACS calibur flow cytometer with CellQuest software (BD Biosciences, Mountain View, CA).
Immunohistochemistry. Kidneys were embedded in "Tissue-Tek" OCT compound (Miles, Elkhart, IL), snap frozen, sectioned (8 m) onto Vectabond slides (Vector Laboratories, Burlingame, CA), and fixed in 95% ethanol. The sections were blocked with 10% donkey serum, followed by incubation with rat anti-Dectin-1 (14) , antineutrophil (clone 7/4) (Serotec), anti-F4/80 (Caltag), or their isotype control antibodies in 1% bovine serum albumin in phosphate-buffered saline. After washing in phosphate-buffered saline, the sections were incubated with anti-rat antibody (Molecular Probes) and 300 nM 4',6-diamidino-2phenylindole (Molecular Probes). Cover slips were mounted with Prolong Anti-Fade (Molecular Probes), and the slides were examined on a fluorescent microscope.
Statistics. Data were summarized by the mean and SEM. Group mean responses were compared by analysis of variance and pairwise multiple comparison testing (the least significant difference procedure or Tukey's procedure for cases where analysis of variance was not significant). Flow data were normalized to the mean percent positive cells for the untreated control for each time interval. Control values were set to 1.0. Probability levels of 0.05 or smaller were considered significant.
RESULTS

Dectin-1 Expression on Blood, Spleen, and Peritoneal Leukocytes in Mice With
Polymicrobial Sepsis. The effect of polymicrobial sepsis on Dectin-1 levels was determined by measuring Dectin-1 expression on the blood leukocytes of mice that had undergone CLP. Initial examination of Dectin-1 expression in control mouse leukocytes revealed three populations of peripheral blood Dectin-1-expressing cells (Fig. 1A) . Approximately, 30% to 60% of blood leukocytes were negative for Dectin-1 ( Fig. 1A) . Most Dectin-1-positive blood leukocytes have high levels of Dectin-1 expression (Dectin-1 high , Fig. 1A ). After CLP, there was a shift to a lower level of Dectin-1 expression (Dectin-1 low , Fig. 1A ). This shift reflects a reduction in the number of Dectin-1 receptors found on the surface of the cells. The data described below focus on the leukocyte populations that show a shift from normal levels of Dectin-1 expression (Dectin-1 high ) to decreased Dectin-1 expression (Dectin-1 low ).
CLP significantly decreased Dectin-1 high -expressing blood leukocytes by 51.4% and 50.9% at 3 hours when compared with control and sham surgery, respectively ( Fig. 1B ; p Ͻ 0.05). In contrast, Dectin-1 low -expressing cells increased in response to CLP at 3 hours postoperatively when compared with control (146%) and to sham (54.5%) (data not shown, p Ͻ 0.05). The percentages of Dectin-1 high -and Dectin-1 low -positive cells returned to baseline by 12 hours (Fig. 1B and data not shown). Splenic leukocytes from CLP animals showed a significant decrease in the percentage of Dectin-1-expressing cells (19.6%) when compared with sham at 12 hours postoperatively ( Fig. 1C ; p Ͻ 0.05). The percentage of Dectin-1-positive peritoneal leukocytes from mice with CLP sepsis showed a significant 774% increase 12 hours postoperatively when compared with sham surgery mice ( Fig. 1D ; p Ͻ 0.05). These data indicate that CLP alters leukocyte Dectin-1 expression in the blood, spleen, and peritoneal cavity.
Dectin-1 Expression on Blood Neutrophils in Mice With Polymicrobial Sepsis.
Leukocyte phenotype was determined to more critically examine changes in Dectin-1 expression in CLP sepsis. Although there was no change in blood neutrophil numbers, CLP decreased Dectin-1-expressing blood neutrophils when compared with control and sham animals ( Fig. 2A) . Specifically, CLP decreased the percentage of Dectin-1-positive blood neutrophils by 41.8% (vs. control) and 43.8% (vs. sham surgery) at 3 hours ( Fig.  2B ; p Ͻ 0.05). By 12 hours, the percentage of Dectin-1-positive blood neutrophils was decreased by 53.2% vs. control ( Fig. 2B ; p Ͻ 0.05). There were no sig-nificant changes in the percentage of blood monocytes or lymphocytes or in the percentage of these cells that expressed Dectin-1 at either 3 or 12 hours postoperatively (data not shown). In the spleen, CLP altered only the percentage of macrophages (11.2% decrease, p Ͻ 0.05) at 6 hours postoperatively ( Fig. 2C ). There were no changes in the percentage of neutrophils or lymphocytes, nor were there changes in the percentage of neutrophils, macrophages, or lymphocytes that expressed Dectin-1 at any of the time intervals (data not shown).
Blood and Splenic Leukocyte Dectin-1 Expression in Mice With Systemic C. albicans Infection. To compare the in vivo effects of another clinically relevant infection model to polymicrobial sepsis, fungal sepsis was induced in mice by injection of C. albicans, and Dectin-1 expression was analyzed. Overall, the percentage of Dectin-1 high -positive cells was increased in both the blood and spleens from C. albicans-infected mice when compared with controls ( Fig. 3, A and B) . Increases of 71.8%, 65.7%, 82.9%, and 118% (p Ͻ 0.05) were observed in Dectin-1 high -positive blood leukocytes on days 3, 5, 7, and 14 of infection, respectively (Fig. 3C ). The percentage of Dectin-1 low -positive cells was decreased by 20.9% at 5 days and increased by 26.3% at 14 days (p Ͻ 0.05; data not shown). The percentage of Dectin-1-expressing splenic leukocytes showed an 86.5% (p Ͻ 0.05) increase at day 7 postinfection (Fig.  3D ). Because Dectin-1 expression has been reported to vary among the different leukocytes (11, 12, 14) , cells were analyzed for phenotype. In the blood, the percentage of neutrophils was significantly increased by 107%, 98.3%, and 76.2% on days 3, 5, and 14, respectively with C. albicans infection (p Ͻ 0.05, data not shown). C. albicans infection increased the percentage of splenic neutrophils by 353% and 216% at 7 and 14 days, respectively (p Ͻ 0.05, data not shown). There was a corresponding decrease in the percentage of blood and splenic T lymphocytes with C. albicans infection, although there was no change in the percentage of blood or splenic monocytes (data not shown). Therefore, one means by which C. albicans infection increased Dectin-1 in the blood and spleen was by increasing the percentage of neutrophils.
Alterations in Neutrophil Population Dynamics and Dectin-1 Expression in
Mice With Systemic Infection With C. albicans. As noted above, C. albicans in- fection results in an influx of neutrophils, which normally express high levels of Dectin-1 (12) . However, the amount of membrane-associated Dectin-1 expressed by neutrophils, as measured by mean fluorescence of Dectin-1, was decreased in response to C. albicans infection (Fig. 3 , E and F). On days 7 and 14 postinfection, Dectin-1 fluorescence on blood neutrophils was decreased by 52.6% and 50.2%, respectively (p Ͻ 0.05) (Fig. 3E ). Dectin-1 fluorescence was decreased on splenic neutrophils on days 3 and 7 postinfection (49.0% and 53.3%, respec-tively, p Ͻ 0.05) (Fig. 3F ). Although C. albicans infection decreased the percentage of T cells, it increased the percentage of splenic T lymphocytes that express Dectin-1. The percentage of Dectin-1positive splenic T cells was increased on days 3 (36.6%) and 7 (23.3%) when compared with controls (p Ͻ 0.05, data not shown). From these data, we conclude that leukocyte Dectin-1 response to C. albicans infection is complex and involves both alterations in leukocyte population dynamics and membrane Dectin-1 expression. However, the overall effect is an increase in blood and splenic Dectin-1 levels.
Dectin-1 Positivity in C. albicans-Induced Renal Lesions. The kidneys are a primary site of infection and colonization in murine C. albicans infection (9, 27) . Therefore, renal Dectin-1 expression was examined in C. albicans infection by immunohistochemistry. Dectin-1 expression (green) was increased in the kidneys of C. albicans-infected mice (Fig. 4B,  white arrows) . Specifically, Dectin-1 expression was increased in the area of renal lesions (Fig. 4B, white arrows) when compared with kidneys from normal control mice (Fig. 4A ). Higher magnification shows Dectin-1-positive cells (Fig. 4D,  arrow) in the infected kidney, whereas the control kidney shows very little Dectin-1 positivity (Fig. 4C ). Immunophenotyping of sequential sections revealed that Dectin-1 positivity colocalized to areas containing primarily macrophages (in red) ( Fig. 4E ) and small numbers of neutrophils (in red) (Fig. 4F) . Thus, the increased Dectin-1 expression observed in the kidneys of mice with C. albicans infection is due to an influx of Dectin-1positive macrophages, and, to a lesser extent, neutrophils.
The Effect of Glucan and Nonglucan PAMPs on Dectin-1 Expression on Primary Neutrophils In Vitro. Our data indicate that clinically relevant infections alter Dectin-1 levels via two mechanisms, i.e., changes in the number of Dectin-1positive leukocytes and modulation of Dectin-1 expression on leukocytes. In an effort to elucidate the mechanisms responsible for in vivo changes in Dectin-1 membrane expression, neutrophils were treated with S. cerevisiae glucan, C. albicans blastospore glucan, C. albicans hyphal glucan, LPS, mannan, or combinations of the above and evaluated for Dectin-1 surface expression. Glucan from all sources resulted in a loss of Dectin-1 from the neutrophil cell surface (Fig. 5 ). S. cerevisiae glucan reduced Dectin-1 levels by 51.0% (p Ͻ 0.05) ( Fig. 5 ). C. albicans glucan had similar effects on Dectin-1 expression with the blastospore glucan decreasing Dectin-1 levels by 57.6%, and the hyphal glucan decreased Dectin-1 by 54.2% (Fig. 5 , p Ͻ 0.05). Neither the LPS alone, nor the mannan alone, significantly altered the Dectin-1 expression ( Fig. 5 ). However, when neutrophils were treated with either LPS or mannan in combination with glucan changes in Dectin-1 levels that were comparable to treatment with glucan alone were observed, i.e., mannan with the C. albicans blastospore glucan reduced Dectin-1 levels by 57.2% (p Ͻ 0.05), and LPS and S. cerevisiae glucan reduced Dectin-1 levels by 32.8% ( Fig. 5; p Ͻ 0.05) . Thus, glucan is the only PAMP tested that altered Dectin-1 on neutrophils. To ensure that the observed decreases in Dectin-1 expression were not due to increased apoptosis induced by the PAMPs, the percentage of apoptotic neutrophils was measured 3 hours after PAMP treatment. LPS treatment decreased the percentage of apoptotic cells by 61.0% and the LPS and glucan treatment decreased the percentage of apoptotic cells by 62.3% when compared with control (data not shown). None of the glucans alone or in combination with mannan significantly altered the percentage of apoptotic cells when compared with media-treated cells (data not shown). Thus, the effects of the glucans on neutrophils Dectin-1 is not due to induction of apoptosis.
The Effect of Inflammatory Cytokines on Dectin-1 Expression on Primary Neutrophils In Vitro. Willment et al (28) have reported that Dectin-1 expression can be modulated by cytokines in vitro. CLP sepsis and C. albicans infection are known to up-regulate a variety of cytokines, including TNF␣ {10869}, IL-6 (22) , and IL-17 (29) . To determine whether circulating cytokines were responsible for the changes in Dectin-1 expression, neutrophils were treated with varying concen-trations of TNF␣, IL-6, IL-17, or L cellconditioned media and analyzed for Dectin-1 expression. None of the cytokines or the L cell-conditioned media altered neutrophil Dectin-1 levels (data not shown). Therefore, the effect of sepsis on leukocyte Dectin-1 expression may not be attributable to circulating cytokines.
DISCUSSION
This is the first report describing regulation of leukocyte Dectin-1 expression in response to clinically relevant models of in vivo fungal or polymicrobial infection. We observed that C. albicans infection resulted in an increase in blood and splenic Dectin-1. In contrast, Dectin-1 was decreased with polymicrobial sepsis. Thus, the regulation of leukocyte Dectin-1 seems to be a dynamic process that is influenced by the type of infection the host encounters. Dectin-1 has been proposed to be a pivotal PRR for fungal infections (30) . The fact that leukocyte Dectin-1 is modulated in response to polymicrobial sepsis may indicate a role for this PRR in nonfungal infections as well.
After C. albicans infection, there was an overall increase in Dectin-1 levels in the blood, spleen, and kidneys of infected mice. Recent work from our laboratory revealed that systemic administration of pure glucan resulted in loss of Dectin-1 expression on blood leukocytes because of internalization of the Dectin-1/glucan complex (17) . It has been shown that systemic fungal infections increase levels of circulating glucan (31) . Therefore, the increase in Dectin-1 levels in fungal sepsis may seem counterintuitive. However, the increase in Dectin-1 levels in C. albicans infection was due primarily to an increase in the proportion of blood and splenic neutrophils and a decrease in the proportion of T lymphocytes. Because neutrophils express large levels of Dectin-1, although T cells express none except in a small subset (12) , this alteration in cell population dynamics would, in part, explain the increase in Dectin-1. We have reported that administration of fungal mannans, but not glucans, induces neutrophilia in vivo (17) . Additionally, in the spleen, there is an increase in the percentage of T lymphocytes that express Dectin-1 with C. albicans infection. This could be due to an expansion of the subset of T cells that express Dectin-1 or due to a loss of splenic T cells that are Dec- were harvested on day 7 of infection and stained with anti-Dectin-1 antibody (2a11) before flow cytometric analysis (representative histograms). In panels C (blood) and D (spleen), cells were harvested, stained with 2a11, and analyzed for percent positive cells by flow cytometry. In panels E (blood) and F (spleen), cells were harvested, stained with 2a11 and antineutrophil, and analyzed for mean fluorescence of Dectin-1 on the neutrophil population by flow cytometry. The data were normalized to the unchallenged control group, which was set at 1. n ϭ 3/group/time interval, values are means Ϯ SEM, *indicates p Ͻ 0.05 compared with control at each time point.
tin-1 negative. The cause of this increase in Dectin-1-positive splenic T lymphocytes is not known; however, this increase does contribute to the overall in-crease in Dectin-1 found in the spleen of C. albicans-infected mice. In contrast, we found that levels of cell surface Dectin-1 on blood and splenic neutrophils were decreased. We speculate that this was due to the internalization of Dectin-1 upon binding C. albicans glucan, a supposition supported by the in vitro neutrophil experiments. Thus, the overall increase in Dectin-1 levels observed in the blood and spleens of C. albicans-infected mice may be the result of the opposing influences of two fungal PAMPs, glucan and mannan, on Dectin-1, i.e., mannan induces neutrophilia, whereas glucan results in decreased membrane Dectin-1 positivity. The net effect of fungal infection was increased Dectin-1 levels systemically. We also observed an increase in Dectin-1-positive cells surrounding fungal foci in C. albicans-infected mice. The increased Dectin-1 expression was due to an influx of Dectin-1-positive macrophages and, to a lesser extent, neutrophils. We speculate that this is an attempt to contain the fungal pathogen in the renal parenchyma.
Neutrophils and macrophages are integral to the defense against fungal infections (32) . These cells express high levels of Dectin-1, which is a proposed sentinel receptor for fungal infections (33, 34) . Therefore, an increase in Dectin-1expressing cells in the blood, spleen, and kidney may be interpreted as an innate immune response to candidal infection. However, the increase in Dectin-1positive cells was not sufficient to clear the fungal pathogen, nor was it sufficient to alter disease outcome. There are several possible explanations for this observation. First, the C. albicans challenge dose may be of sufficient magnitude to overwhelm innate host defenses. Second, it is possible that the reduced expression of Dectin-1 by neutrophils leaves these cells less able to respond to the fungal organisms. The latter supposition is supported by work by Taylor et al (20) who have demonstrated that Dectin-1 knockout mice are more susceptible to C. albicans infection.
In contrast to fungal infection, we found that polymicrobial sepsis decreased blood Dectin-1 by decreasing the percentage of Dectin-1-expressing peripheral neutrophils. The mechanisms responsible for the decrease in Dectin-1 expression are unclear; however, it is possible that CLP may result in elevated levels of circulating glucans. Digby et al (31) demonstrated that septic patients have increased circulating glucan levels, regardless of infectious etiology. Polymicrobial sepsis was induced by perforation of the ileocecal pouch, resulting in the intro- duction of cecal contents into the abdominal cavity inducing peritonitis. Glucans from the gut microflora may have been absorbed into the systemic circulation and bound to Dectin-1 with subsequent internalization of the receptor-ligand complex (17) . Alternatively, other factors have been shown to affect Dectin-1 expression (28) . Willment et al (28) have reported that certain cytokines and LPS negatively regulate Dectin-1 RNA expression on macrophages in vitro. Studies have shown that septic patients have elevated levels of cytokines and circulating LPS (35) . Any or all of these factors might contribute to the decreased cell surface expression of Dectin-1 that was observed; however, the in vitro studies revealed that glucan administration alone resulted in loss of Dectin-1 from the neutrophil cell surface. Nonglucan PAMPs, such as LPS and mannan, did not alter neutrophil Dectin-1 unless the cells were also treated with glucan. Additionally, treatment with TNF␣, IL-6, IL-17, or L cellconditioned media had no effect on neutrophil cell surface Dectin-1. Thus, to date, only glucans seem to decrease Dectin-1 surface expression on neutrophils. Therefore, it is likely that the loss of Dectin-1-positive neutrophils in polymicrobial sepsis is due to elevated levels of circulating glucans.
Of further interest is the change in Dectin-1 expression by peritoneal cells with CLP sepsis. In contrast to the blood data, the percentage of Dectin-1-peritoneal macrophages was increased when compared with sham-operated animals. One factor in the difference between the sham and CLP values is a decrease in the sham value as compared with the other time intervals. The cause of this decrease is not known, but is likely due to factors released into the peritoneal cavity by the trauma of surgery. Although this study has demonstrated that only glucans seem to affect Dectin-1 expression in neutrophils, the same is not the case with macrophages. Previous work has shown that IL-10, dexamethasone, and LPS will all negatively affect Dectin-1 expression by macrophages (28) . The second factor in the difference would be the increased percentage of Dectin-1-positive cells with CLP. Previous studies have shown that resident peritoneal macrophages express Dectin-1 at low levels, but that macrophages elicited by an inflammatory stimulus, i.e., sterile peritonitis, express Dectin-1 at high levels (12) . Additionally, granulocyte monocyte colony stimulating factor treated macrophages express higher levels of Dectin-1 (28) . It is possible that the levels of granulocyte monocyte colony stimulating factor in the local milieu are increased with an inflammatory insult originating in the peritoneal cavity, and this leads to an increase in the expression of Dectin-1 by the resident peritoneal macrophages.
The consequences of the decrease in Dectin-1-positive neutrophils in polymicrobial sepsis are unclear. Critically ill patients have been shown to be more susceptible to opportunistic fungal infection (2, 3) . It is possible that reduced Dectin-1 expression is responsible for this increase in susceptibility. Further studies examining human Dectin-1 expression after critical illness will be necessary to determine whether this is the case. Additional studies are also warranted to better determine what role Dectin-1 might be playing in response to polymicrobial sepsis.
One possible limitation of this study as a comparison of different models of infection is the difference in kinetics between the two models of infection. CLP-induced polymicrobial sepsis is an initially localized infection, which results in acute shock with rapid mortality occurring as soon as 22 hours postoperatively. Thus, only the immediate response of Dectin-1 to acute shock could be examined without skewing the results toward survivors. With intravenous administration of C. albicans, however, the infection is rapidly disseminated via the blood. There is no demonstrable acute shock phase, and candidemia results in a more chronic disease in which the mice are unlikely to succumb before day 6 of infection. This limitation does not alter the significance of the findings, but future studies are warranted to compare infectious diseases with similar clinical courses.
